EBC-46

Mechanism of Action

cGAS-STING Pathway and EBC-46: How Cytosolic DNA Sensing Links Cell Death to Antitumour Immunity

cGAS-STING is the innate immune sensor that detects cytosolic DNA. Where does it fit in the picture of how EBC-46 and tigilanol tiglate trigger antitumour responses?

Regulatory

South Korea MFDS Botanical Supplement Framework: How Blushwood Berry Products Are Classified

South Korea's MFDS uses three distinct categories for botanical products: Health Functional Foods, Korean traditional medicines, and general foods. Where would blushwood berry extract fit?

Mechanism of Action

EBC-46 and Pattern Recognition Receptors: How Tigilanol Tiglate Engages Innate Immune Sensors

Tigilanol tiglate's mechanism extends beyond PKC activation. It engages innate immune pattern recognition receptors. Here is what the literature shows.

Regulatory

Singapore HSA Framework for Botanical Supplements: What It Means for EBC-46 Imports

Singapore's Health Sciences Authority regulates health supplements under a notification framework. Here is how that affects EBC-46 supplement category imports.

Mechanism of Action

Necroptosis and EBC-46: The RIPK1/RIPK3/MLKL Pathway in Tigilanol Tiglate Cell Death

Necroptosis is a regulated, lytic form of cell death distinct from apoptosis. We examine where tigilanol tiglate research intersects the RIPK1/RIPK3/MLKL axis.

Regulatory

UK MHRA Traditional Herbal Registration: How Botanical Supplements Like EBC-46 Fit the Framework

How the UK MHRA distinguishes Traditional Herbal Registrations from food supplements, and where blushwood berry extract products sit in that framework today.

Consumer Reports

Bottle Material and EBC-46 Tincture Stability: What Users Report About Glass vs. Plastic Storage

A summary of user reports on how bottle material — amber glass vs. plastic — affects perceived stability, taste and shelf life of EBC-46 blushwood berry tinctures.

Botany

Altitudinal Variation and EBC-46 Concentration in Fontainea picrosperma: How Elevation Shapes Blushwood Berry Chemistry

How elevation, temperature gradients and microclimate at different altitudes influence tigilanol tiglate concentration in Fontainea picrosperma seeds.

Human Trials

Phase III Pivotal Trial Design Considerations for Tigilanol Tiglate (EBC-46): What a Confirmatory Study Would Need

Methodological considerations that would shape a Phase III confirmatory trial for tigilanol tiglate, including endpoints, controls, and patient selection.

Mechanism of Action

TRAIL Receptor Pathway and EBC-46: Death Receptor Signalling in Tigilanol Tiglate-Induced Cell Death

How tigilanol tiglate, the active diterpene ester in EBC-46 research, intersects with the TRAIL/death receptor pathway and extrinsic apoptosis in tumour biology.

Regulatory

South Africa SAHPRA and EBC-46: How Complementary Medicines Regulations Apply to Blushwood Berry Supplements

How South Africa's SAHPRA regulates complementary medicines and where blushwood berry extract supplements like EBC-46 fit within the country's established framework.

Consumer Reports

Subjective Energy and Wellbeing After EBC-46 Supplement Use: User Report Patterns

A neutral pattern review of self-reported energy and wellbeing observations from EBC-46 supplement users — what people commonly describe, methodological limits, and how to evaluate such reports.